The U.S. Food and Drug Administration on Wednesday granted traditional approval to Eli Lilly and Company’s Jaypirca for ...

Cancer patient killed by ‘toxic mold’ while recuperating in Airbnb, family says - Exclusive: ‘The loss of a loved one is a ...

Crinetics Pharmaceuticals, Inc. today announced the first patient has been dosed in the Phase 1/2 study evaluating CRN09682 in patients with metastatic or locally advanced somatostatin receptor type 2 ...

The FDA has approved pirtobrutinib (Jaypirca) treatment for adults with relapsed/refractory chronic lymphocytic leukemia or ...

Dave Coulier credits family, fans and co-stars for supporting his non-Hodgkin lymphoma recovery as he reveals a new cancer ...

XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the ...

The FDA has approved pirtobrutinib for certain adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.The new indication applies to adults who previously have ...

ADC Therapeutics (ADCT) announced updated data from the LOTIS-7 Phase 1b open-label clinical trial evaluating the safety and efficacy of Zynlonta ...

Soligenix Inc. (NASDAQ: SNGX) today announces its placement in an editorial published by BioMedWire ("BMW"), one of 75+ brands ...

The author shares a deeply personal account of losing a sister to cancer after a decade-long battle, highlighting the emotional complexity of anticipatory grief. Despite numerous end-of-life ...

As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...

After a breast cancer diagnosis at age 47, surviving to the 10-year mark felt almost like an impossible dream. But the ...